Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin in Pediatric Complex Vascular Anomalies
NCT04598204Phase 3Unknown
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Dec 2017
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in kaposiform hemangioendothelioma (KHE), tufted angioma (TA), vascular malformations (VM), sponsored by Southern Medical University Zhujiang Hospital. Status: unknown.
02
Drugs
sirolimus
03
Conditions
kaposiform hemangioendothelioma (KHE)tufted angioma (TA)vascular malformations (VM)
Beyond the preview
Go deeper on NCT04598204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04598204.